Search results for "CEM"

showing 10 items of 3487 documents

Imaging of Ventriculoperitoneal Shunt Complications: Comparison of Whole Body Low-Dose Computed Tomography and Radiographic Shunt Series.

2016

OBJECTIVE To determine diagnostic value and radiation exposure of low-dose computed tomography (LD-CT) compared to radiographic shunt series (SS) for the detection of ventriculoperitoneal (VP) shunt complications. METHODS Fourteen VP shunts were implanted in 7 swine cadavers. Mechanical complications were induced in 50% of VP shunts. Low-dose CT (80 kVp, 10 mAs, Pitch = 1.5) and SS were acquired. Dose area product (DAP) and effective doses for SS and LD-CT were collected. Scoring of diagnostic confidence and blinded readings of SS and CT data were performed. RESULTS The sensitivity of LD-CT was high (0.97; 95% confidence interval, 0.91-1.00) with excellent interobserver agreement (κ = 0.88)…

medicine.medical_specialtySwineRadiographyComputed tomographyRadiation DosageEffective dose (radiation)Sensitivity and SpecificityVentriculoperitoneal Shunt030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRadiation ProtectionmedicineAnimalsRadiology Nuclear Medicine and imagingMedical physicsSingle-Blind MethodWhole Body Imagingmedicine.diagnostic_testbusiness.industryLow doseReproducibility of ResultsRadiation ExposureConfidence intervalRadiographic Image EnhancementDose area productRadiographic Image Interpretation Computer-AssistedTomographybusinessNuclear medicineTomography X-Ray Computed030217 neurology & neurosurgeryShunt (electrical)Journal of computer assisted tomography
researchProduct

Takotsubo Syndrome After Mitral Valve Replacement: Case Report and Brief Review of the Literature

2015

RANSIENT LEFT VENTRICULAR apical ballooningsyndrome, also known as Takotsubo or stress-inducedcardiomyopathy, is a cardiac disease characterized by transientleft ventricular dysfunction, electrocardiographic changes mim-icking an acute coronary syndrome, and release of myocardialcellular necrosis enzymes in the absence of significant lesionsof coronary arteries.

medicine.medical_specialtyTakotsubo syndromeAcute coronary syndromeNecrosisbusiness.industryCardiogenic shockmedicine.medical_treatmentMitral valve replacementDiseasemedicine.diseaseCoronary arteriesAnesthesiology and Pain Medicinemedicine.anatomical_structureInternal medicinecardiovascular systemmedicineCardiologyStress induced cardiomyopathycardiovascular diseasesmedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of Cardiothoracic and Vascular Anesthesia
researchProduct

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

2019

medicine.medical_specialtyTazobactamLetterContinuous Renal Replacement Therapybusiness.industrymedicine.medical_treatmentCritical IllnessCEFTOLOZANE/TAZOBACTAMlcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Critical Care and Intensive Care MedicineCephalosporinsmedicineHumansRenal replacement therapyIntensive care medicinebusinessCritical Care
researchProduct

Release of non-neuronal acetylcholine from the isolated human placenta is affected by antidepressants.

2007

Non-neuronal acetylcholine (ACh) is released from the human placenta into the extracellular space via organic cation transporters (OCTs). The present experiments investigated whether ACh release from epithelial cells is affected by drugs which are substrates of OCTs. The antidepressant drugs amitriptyline and doxepine were tested as both substances are not approved for pregnant women but frequently used. Release of ACh was measured in 10 min intervals over a period of 100 min. Test substances were added from t=50 min of incubation onwards. The effect was calculated by comparing the ACh release of the last three samples (t=70-100 min; B2) with that immediately before the application of the t…

medicine.medical_specialtyTime FactorsAmitriptylinePlacentaVasodilator AgentsPharmacologyIn Vitro TechniquesGeneral Biochemistry Genetics and Molecular BiologyTheophyllinePregnancyInternal medicinemedicineExtracellularHumansHypoglycemic AgentsAmitriptylineGeneral Pharmacology Toxicology and PharmaceuticsIncubationNeuronsOrganic cation transport proteinsbiologyDose-Response Relationship DrugChemistryHuman placentaGeneral MedicineAcetylcholineAntidepressive AgentsMetforminNon neuronal acetylcholineEndocrinologybiology.proteinMinoxidilAntidepressantFemaleDoxepinAcetylcholinemedicine.drugLife sciences
researchProduct

Influence of long-term postmenopausal hormone-replacement therapy on estimated structural bone strength: A study in discordant monozygotic twins

2010

Although postmenopausal hormone-replacement therapy (HRT) is known to prevent fractures, knowledge on the influence of long-term HRT on bone strength and its determinants other than areal bone mineral density is scarce. This study used a genetically controlled design with 24 monozygotic female twin pairs aged 54 to 72 years in which one cotwin was using HRT (mean duration 8 years) and the other had never used HRT. Estimated bone strength, cross-sectional area, volumetric bone mineral density, bone mineral mass, and cross-sectional density and mass distributions were assessed in the tibial shaft, distal tibia, and distal radius with peripheral computed tomography (pQCT). In the tibial shaft,…

medicine.medical_specialtyTime FactorsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentDentistryMonozygotic twin030209 endocrinology & metabolismBone and Bones03 medical and health sciences0302 clinical medicineBone strengthBone DensitymedicineHumansPostmenopausal Hormone Replacement TherapyOrthopedics and Sports Medicineta315Aged030304 developmental biologyBone mineral0303 health sciencesPostmenopausal womenAnthropometrybusiness.industryEstrogen Replacement Therapyta3141Hormone replacement therapy (menopause)Organ SizeTwins Monozygoticta3142Middle AgedHormonesConfidence intervalSurgerymedicine.anatomical_structureBody CompositionFemaleCortical boneDiaphysesSelf ReportbusinessJournal of Bone and Mineral Research
researchProduct

Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possi…

2009

Pompe disease is a rare, autosomal-recessive disorder which results from a defect in the lysosomal enzyme acid alpha-glucosidase (GAA). The onset of this disease is highly variable, with infantile types being the most severe. Traditionally, lymphocytes, fibroblasts or muscle biopsies were necessary for enzyme activity measurement, because these materials do not express maltase-glucoamylase (MGA) that interferes with the assay. Recently, acarbose was found to inhibit MGA activity selectively, so that dried blood became accessible for GAA assessment.To evaluate the diagnostic efficacy of GAA measurement in dried blood specimens (DBSs) in comparison with lymphocytes. If DBSs provided reliable …

medicine.medical_specialtyTime FactorsLymphocyteBiopsyNeonatal ScreeningInternal medicineBiopsyGeneticsmedicineHumansFalse Positive ReactionsFluorometryLymphocytesGenetics (clinical)Acarbosechemistry.chemical_classificationNewborn screeningmedicine.diagnostic_testbiologybusiness.industryGlycogen Storage Disease Type IIMusclesInfant NewbornReproducibility of Resultsalpha-GlucosidasesEnzyme replacement therapyFibroblastsHydrogen-Ion ConcentrationEnzyme assaymedicine.anatomical_structureEndocrinologyEnzymechemistryCarbohydrate Metabolism Disorderbiology.proteinFeasibility Studiesbusinessmedicine.drugJournal of inherited metabolic disease
researchProduct

Efficient 3D Deep Learning for Myocardial Diseases Segmentation

2021

Automated myocardial segmentation from late gadolinium enhancement magnetic resonance images (LGE-MRI) is a critical step in the diagnosis of cardiac pathologies such as ischemia and myocardial infarction. This paper proposes a deep learning framework for improved myocardial diseases segmentation. In the first step, we build an encoder-decoder segmentation network that generates myocardium and cavity segmentations from the whole volume, followed by a 3D U-Net based on Shape prior to identifying myocardial infarction and myocardium ventricular obstruction (MVO) segmentations from the encoder-decoder prediction. The proposed network achieves good segmentation performance, as computed by avera…

medicine.medical_specialtyTraining setmedicine.diagnostic_testbusiness.industryDeep learningIschemiaMagnetic resonance imagingmedicine.diseaseInternal medicinecardiovascular systemmedicineCardiologyLate gadolinium enhancementSegmentationcardiovascular diseasesArtificial intelligenceMyocardial infarctionbusinessVolume (compression)
researchProduct

Successful transcatheter aortic valve-in-valve implantation in a patient having a chronic type A aortic dissection

2017

medicine.medical_specialtyTranscatheter aortic030204 cardiovascular system & hematologyTranscatheter Aortic Valve Replacement03 medical and health sciencesImaging Three-Dimensional0302 clinical medicineInternal medicineHumansMedicineAgedAortic dissectionAortic Aneurysm Thoracicbusiness.industryAngiographyAortic Valve Stenosis030229 sport sciencesmedicine.diseaseEchocardiography DopplerValve in valveAortic ValveHeart Valve ProsthesisChronic DiseaseCardiologyFemaleTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Surgery for Transcatheter Aortic Valve Replacement Endocarditis—A Single-Center Series

2019

medicine.medical_specialtyTranscatheter aorticValve replacementbusiness.industrymedicine.medical_treatmentmedicineEndocarditisSingle Centerbusinessmedicine.diseaseSurgeryThe Thoracic and Cardiovascular Surgeon
researchProduct

Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial.

2021

Aims Despite aortic stenosis (AS) relief, patients undergoing transcatheter aortic valve implantation (TAVI) are at increased risk of developing heart failure (HF) within first months of intervention. Sodium-glucose co-transporter 2 (SGLT-2) inhibitors have been shown to reduce the risk of HF hospitalization in individuals with diabetes mellitus (DM), reduced left ventricular ejection fraction (LVEF) and chronic kidney disease (CKD). However, the effect of SGLT-2 inhibitors on outcomes after TAVI is unknown. The Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) trial is designed to assess the clinical benefit and safety of the SGLT-2 inhibitor dapagliflozin in patients …

medicine.medical_specialtyTranscatheter aorticVentricular Function Leftlaw.inventionTranscatheter Aortic Valve Replacementchemistry.chemical_compoundRandomized controlled trialGlucosideslawInternal medicineDiabetes mellitusmedicineHumansProspective StudiesDapagliflozinBenzhydryl CompoundsHeart FailureEjection fractionbusiness.industryStroke VolumeAortic Valve Stenosismedicine.diseaseStenosisTreatment OutcomechemistryHeart failureAortic ValveCardiologyCardiology and Cardiovascular MedicinebusinessKidney diseaseEuropean journal of heart failureReferences
researchProduct